ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Marcopolo Sa

Marcopolo Sa (POMO4R)

7.70
0.00
(0.00%)
Closed February 26 3:55PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
7.70
Bid
0.00
Ask
0.00
Volume
9,235,400
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
7.70
Open
-
Last Trade
435100
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

POMO4R Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

POMO4R - Frequently Asked Questions (FAQ)

What is the current MARCOPOLO PN share price?
The current share price of MARCOPOLO PN is R$ 7.70
What is the 1 year trading range for MARCOPOLO PN share price?
MARCOPOLO PN has traded in the range of R$ 0.00 to R$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AZTE3Azevedo & Travassos Energia Sa
R$ 1.19
(14.42%)
9.77M
VSTE3Veste S.A. Estilo
R$ 6.09
(9.53%)
187k
BIOM3Biomm SA
R$ 9.92
(8.42%)
162.7k
FRIO3Metalfrio Solutions Sa
R$ 299.97
(7.13%)
100
ABEV3Ambev SA
R$ 11.70
(5.50%)
79.61M
IRBR3IRB BrasilResseguros SA
R$ 44.90
(-18.26%)
6.83M
SEQL3Sequoia Logistica e Transportes SA
R$ 2.05
(-9.29%)
635.9k
WEGE3Weg Sa
R$ 47.85
(-8.68%)
25.73M
AFLT3Afluente Transmissao De Energia Eletrica SA
R$ 6.53
(-8.42%)
200
MRVE3Mrv Engenharia Participacoes Sa
R$ 4.70
(-7.84%)
23.54M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.10
(-1.41%)
134.32M
ABEV3Ambev SA
R$ 11.70
(5.50%)
79.61M
BBDC4Bco Bradesco Sa
R$ 11.54
(-1.95%)
51.82M
CSAN3Cosan SA
R$ 7.00
(-1.69%)
40.06M
COGN3CognaEducacao SA
R$ 1.56
(-1.89%)
35.61M

Discussion

View Full Feed
Jackxkr Jackxkr 1 minute ago
You back trump and his abusers ( drugs,alcohol and women) not the way I was raised. I can tell alot about you by the people you admire.
NWBO
kip128932156 kip128932156 2 minutes ago
Pulte opening statement 
https://www.banking.senate.gov/imo/media/doc/pulte_testimony_2-27-25.pdf

FNMA
DaJester DaJester 2 minutes ago
Funny how someone can read something... quote the transcript... add bold for emphasis... and still completely miss the point being made.

The treasury legal view is they haven't been all paid back, so you know, it's a nice interesting argument, but that's not what the lawyers say, and
FNMA
janice shell janice shell 2 minutes ago
it will be many years before any private company is willing to do exploratory work on land that is littered with unexploded ordinance and where the Russians are still within rocket and artillery range.

Perhaps the agreement contains some requirements that we help clear up that ordnanc
dewophile dewophile 2 minutes ago
Got it. Makes sense that a lawyer would be conflicted out of certain cases (and then such an equivalent doesn’t in fact exist in pharma)
ENTA
QL300 QL300 3 minutes ago
That's a fair bet. We will wait and see. 
NWBO
misterfishman misterfishman 3 minutes ago
Don't buy this turd.you were warned.
KEGS
PennyMillions852 PennyMillions852 4 minutes ago
Over 33 million in volume today! This thing is ready for a break out from this point!🚀
IGPK
Miamifl Miamifl 4 minutes ago
I thought on IHub that that isn't allowed.
BIEL
kund kund 4 minutes ago
More comments on same post. It's good to see people calling out the Clown CEO for his misleading statements. I suspect he'll stop posting on LinkedIn and revert to his usual dog-and-pony shows.

maybe the FDA did advise them not to apply yet, maybe they didn't, we don't know because t
AVXL
KRISGO KRISGO 4 minutes ago
What’s the point of making predictions like that? It’s like throwing a stone in the air—if it lands, he’ll act like he knew it was going to happen.😀
NWBO
The GidDy uP Kid The GidDy uP Kid 4 minutes ago
BBLG, aDDing… that made someone mad 😆  
BBLG
wadegarret wadegarret 4 minutes ago
Valuemind- GERN

Just curious. Do you feel that the drug Rytelo already having flat month over month sales is a sign that the drug is a flop ? I mean I'm starting to have second thoughts about the real potential for the drug if doctors just don't want to use it, and GERN can't even
GERN
The GidDy uP Kid The GidDy uP Kid 5 minutes ago
BBLG aDDing… that made someone mad 😆  
BBLG
downdraft downdraft 5 minutes ago
Volume was up today. I only got about 3 million of those shares.
EMED
Yahsho Yahsho 5 minutes ago
Massive? You call 2.2 million shares sold massive.

CYDY
Jetmek_03052 Jetmek_03052 5 minutes ago
QUIT DEFLECTING!

You’re bending over backward to avoid answering the simplest question: If you claim to support exposing any short position, why aren’t you pushing DBMM to act?

Not my circus, not my monkeys!


The better question is, why aren't YOU
DBMM
learningcurve2020 learningcurve2020 6 minutes ago
It would be one explanation for the action today and faux stock downgrades.

“Wedbush Lowers Geron’s Price Target to $7 from $8, Outperform Raiting Maintained”
GERN
researcher59 researcher59 6 minutes ago
NVDA may be a bit undervalued at $130, but not by much, imho. I think the stock will be range bound between $120 and $150 until the next earnings report in May. We shall see. I will be opportunistically trading it, buying on weakness, selling into strength.
NVDA
karlacorn3 karlacorn3 6 minutes ago
So actual token counts in wallets, and payouts this week. 🗓️?

K
ITUP
downdraft downdraft 6 minutes ago
Here's a direct link an article about Lionheart Health and EMED. If you read carefully through all of these documents, it certainly appears they have big plans for bioelectric stimulation beyond just pain management.

https://lionhearthealthstim.com/lionheart-health-and-electromedic
EMED
arizona1 arizona1 6 minutes ago
It should be a $20 stock. if that! Can't wait for the shareholder's lawsuit.

The picture is bleak, and it’s hard to imagine how the company can get itself out of this perfect hurricane. It seems to me its only way forward is President Donald Trump’s Sharpie.
https://www.fastc
Miamifl Miamifl 6 minutes ago
Art24,   I was disappointed that Biel didn't go at the pace I wanted it to go. And so were you. We had been hoping to see SP of between  .25-3.00 a share, but it didn't happen. I'm still holding out to this company because they're making a lot of progress by the Press Releases that are released by u
BIEL

Your Recent History

Delayed Upgrade Clock